Q2 Earnings Forecast for Chemours Issued By Zacks Research

The Chemours Company (NYSE:CC) – Stock analysts at Zacks Research reduced their Q2 2025 earnings estimates for Chemours in a research note issued to investors on Monday, March 3rd. Zacks Research analyst R. Department now expects that the specialty chemicals company will earn $0.58 per share for the quarter, down from their prior estimate of $0.71. The consensus estimate for Chemours’ current full-year earnings is $2.03 per share. Zacks Research also issued estimates for Chemours’ Q3 2025 earnings at $0.54 EPS, Q2 2026 earnings at $0.69 EPS, FY2026 earnings at $2.39 EPS and FY2027 earnings at $2.67 EPS.

Chemours (NYSE:CC) last posted its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion.

Other analysts have also recently issued research reports about the company. Barclays lowered their price target on Chemours from $23.00 to $19.00 and set an “equal weight” rating on the stock in a report on Monday, February 24th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $25.00 target price on shares of Chemours in a research note on Thursday, December 12th. Morgan Stanley dropped their target price on shares of Chemours from $25.00 to $22.00 and set an “equal weight” rating for the company in a research report on Monday, January 13th. BMO Capital Markets decreased their price target on shares of Chemours from $34.00 to $27.00 and set an “outperform” rating on the stock in a report on Wednesday, February 19th. Finally, The Goldman Sachs Group dropped their price objective on shares of Chemours from $24.00 to $21.00 and set a “neutral” rating for the company in a report on Tuesday, January 7th. Five analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Chemours presently has an average rating of “Hold” and an average target price of $23.11.

Chemours Trading Down 0.7 %

Chemours stock opened at $14.00 on Wednesday. The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68. Chemours has a fifty-two week low of $13.31 and a fifty-two week high of $29.21. The stock has a market cap of $2.09 billion, a P/E ratio of 24.56 and a beta of 1.81. The firm’s fifty day moving average price is $17.63 and its 200-day moving average price is $18.73.

Institutional Investors Weigh In On Chemours

A number of large investors have recently modified their holdings of the stock. FMR LLC lifted its holdings in Chemours by 3.5% in the third quarter. FMR LLC now owns 18,142,202 shares of the specialty chemicals company’s stock worth $368,650,000 after buying an additional 618,361 shares during the period. Vanguard Group Inc. raised its position in shares of Chemours by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 15,223,961 shares of the specialty chemicals company’s stock worth $257,285,000 after acquiring an additional 94,885 shares in the last quarter. Ameriprise Financial Inc. lifted its stake in shares of Chemours by 23.8% in the 4th quarter. Ameriprise Financial Inc. now owns 4,373,172 shares of the specialty chemicals company’s stock valued at $73,907,000 after purchasing an additional 839,849 shares during the period. Millennium Management LLC boosted its position in shares of Chemours by 44.6% during the fourth quarter. Millennium Management LLC now owns 2,507,262 shares of the specialty chemicals company’s stock valued at $42,373,000 after purchasing an additional 773,537 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in Chemours by 1.2% in the third quarter. Geode Capital Management LLC now owns 2,491,748 shares of the specialty chemicals company’s stock worth $50,646,000 after purchasing an additional 28,803 shares during the period. Institutional investors own 76.26% of the company’s stock.

Chemours Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Friday, February 28th. This represents a $1.00 annualized dividend and a yield of 7.14%. Chemours’s dividend payout ratio (DPR) is presently 175.44%.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.